Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | POLO: Olaparib as maintenance treatment for metastatic pancreatic cancer

Michael Hall, MD, MS of the Fox Chase Cancer Center, Philadelphia, PA, talks on the key updates from the POLO trial investigating olaparib as maintenance treatment for metastatic pancreatic cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.